Breast Cancer

Showing NaN - NaN of 142

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Quantitative MRI Assessment of Breast Cancer Therapy Response

Recruiting
  • Breast Cancer
  • Diffusion Weighted Imaging
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Iowa City, Iowa
  • +2 more
Jan 19, 2023

Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Portland, Suwon (AB-201, Cyclophosphamide,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Portland, Oregon
  • +1 more
Jan 12, 2023

Breast Cancer Trial in Worldwide (Atezolizumab, Trastuzumab Emtansine, Placebo)

Recruiting
  • Breast Cancer
  • Alabaster, Alabama
  • +305 more
Jan 10, 2023

Breast Cancer Trial in Worldwide (Inavolisib, Placebo, Palbociclib)

Recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +228 more
Jan 10, 2023

Breast Cancer Trial in Worldwide (trastuzumab, trastuzumab emtansine)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alaska
  • +275 more
Dec 13, 2022

HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • Tucson, Arizona
  • +15 more
Dec 22, 2022

Breast Tumor Female, Breast Cancer, Breast Carcinoma Trial in Portland (Nivolumab, Ipilimumab, Bicalutamide)

Recruiting
  • Breast Neoplasm Female
  • +3 more
  • New York, New York
  • +1 more
Dec 21, 2022

Breast Cancer, Pain Trial in United States (acupuncture therapy, sham acupuncture)

Completed
  • Breast Cancer
  • Pain
  • acupuncture therapy
  • sham acupuncture
  • Antioch, California
  • +46 more
Dec 5, 2022

Breast Cancer Trial in Worldwide (Dato-DXd, Capecitabine, Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +172 more
Dec 1, 2022

Breast Cancer Trial in Greece, Israel, United States (MammaPrint, BluePrint, and Full-Genome Testing)

Recruiting
  • Breast Cancer
  • MammaPrint, BluePrint, and Full-Genome Testing
  • Birmingham, Alabama
  • +117 more
Dec 1, 2022

Breast Cancer Trial in Worldwide (Olaparib, Placebo)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alabama
  • +698 more
Nov 25, 2022

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

    Recruiting
    • Advanced Solid Tumor
    • +7 more
    • PY159 Single agent dose level 1
    • +17 more
    • San Francisco, California
    • +11 more
    Nov 3, 2022

    TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

    Active, not recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Breast Cancer
    • Birmingham, Alabama
    • +111 more
    Oct 25, 2022

    Breast Cancer Trial in Los Angeles, Portland (Ipilimumab, Nivolumab, Core Biopsy/Cryoablation)

    Recruiting
    • Breast Cancer
    • Los Angeles, California
    • +2 more
    Sep 27, 2022

    Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

    Completed
    • Melanoma
    • +25 more
    • Scottsdale, Arizona
    • +10 more
    Sep 27, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)

    Active, not recruiting
    • Breast Cancer
    • Chandler, Arizona
    • +166 more
    Jul 21, 2022

    Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)

    Active, not recruiting
    • Breast Cancer
    • Tucson, Arizona
    • +167 more
    Jul 19, 2022

    Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)

    Active, not recruiting
    • Breast Cancer
    • Anchorage, Alaska
    • +495 more
    Jun 15, 2022

    Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)

    Active, not recruiting
    • Breast Cancer
    • therapeutic conventional surgery
    • whole breast irradiation
    • Hot Springs, Arkansas
    • +349 more
    Jun 16, 2022

    Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

    Recruiting
    • Oncology
    • +16 more
    • E-602
    • Pembrolizumab
    • Grand Rapids, Michigan
    • +4 more
    May 27, 2022

    Breast Cancer Trial in Ireland, United States (bevacizumab, docetaxel, doxorubicin)

    Completed
    • Breast Cancer
    • Bessemer, Alabama
    • +532 more
    Apr 13, 2022

    Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)

    Active, not recruiting
    • Breast Cancer
    • Mobile, Alabama
    • +437 more
    Mar 21, 2022